Curcumin supplementation in the treatment of patients with cancer: a systematic review

Detalhes bibliográficos
Autor(a) principal: Andrade da Anunciação, Taise
Data de Publicação: 2022
Outros Autores: Spindola Garcez, Laís, Miranda Pereira, Emile, Alves de Oliveira Queiroz, Valterlinda, Ribas de Farias Costa, Priscila, Pereira Magalhães de Oliveira, Lucivalda
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/200985
Resumo: Feeding with high levels of phytochemicals, including curcumin, may be a therapeutic option for diseases such as cancer which is a public health problem. The aim of this study was to systematically review the results of clinical trials investigating the effect of oral curcumin supplementation on anti-inflammatory and antioxidant profiles, reduction of PSA levels and degree of dermatitis in radiotherapy treatment in cancer patients. The review was carried out based on the items of the PRISMA Statement. A bias risk assessment was performed according to Cochrane Collaboration criteria. Six studies met the eligibility criteria and were included in the systematic review. The results of this study are based on those obtained in the literature on the effect of curcumin on the anti-inflammatory profile, on reducing dermatitis, on PSA alteration and on anti-oxidant profile for a total of 450 individuals, comprising 259 in the intervention group and 191 in the control group. Some studies have reported improvement in biochemical and clinical indicators, with limited adverse effects and good tolerance. It was not possible to determine, with the desired degree of evidence, the effect of curcumin supplementation in the treatment of cancer patients. It is important to consider the great heterogeneity and methodological weaknesses of the studies, and that it was not possible to perform a meta-analysis of the data available in the literature.
id USP-31_e80c382350df125f6f0312d18313d259
oai_identifier_str oai:revistas.usp.br:article/200985
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Curcumin supplementation in the treatment of patients with cancer: a systematic reviewCurcumin. Cancer. Systematic review. Anti-inflammatory profile. Anti-oxidant profile.Feeding with high levels of phytochemicals, including curcumin, may be a therapeutic option for diseases such as cancer which is a public health problem. The aim of this study was to systematically review the results of clinical trials investigating the effect of oral curcumin supplementation on anti-inflammatory and antioxidant profiles, reduction of PSA levels and degree of dermatitis in radiotherapy treatment in cancer patients. The review was carried out based on the items of the PRISMA Statement. A bias risk assessment was performed according to Cochrane Collaboration criteria. Six studies met the eligibility criteria and were included in the systematic review. The results of this study are based on those obtained in the literature on the effect of curcumin on the anti-inflammatory profile, on reducing dermatitis, on PSA alteration and on anti-oxidant profile for a total of 450 individuals, comprising 259 in the intervention group and 191 in the control group. Some studies have reported improvement in biochemical and clinical indicators, with limited adverse effects and good tolerance. It was not possible to determine, with the desired degree of evidence, the effect of curcumin supplementation in the treatment of cancer patients. It is important to consider the great heterogeneity and methodological weaknesses of the studies, and that it was not possible to perform a meta-analysis of the data available in the literature.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2022-11-08info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/200985Brazilian Journal of Pharmaceutical Sciences; Vol. 57 (2021)Brazilian Journal of Pharmaceutical Sciences; v. 57 (2021)Brazilian Journal of Pharmaceutical Sciences; Vol. 57 (2021)2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/200985/185166https://www.revistas.usp.br/bjps/article/view/200985/185167Copyright (c) 2022 Brazilian Journal of Pharmaceutical Scienceshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessAndrade da Anunciação, Taise Spindola Garcez, LaísMiranda Pereira, EmileAlves de Oliveira Queiroz, ValterlindaRibas de Farias Costa, PriscilaPereira Magalhães de Oliveira, Lucivalda2022-11-08T19:43:44Zoai:revistas.usp.br:article/200985Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2022-11-08T19:43:44Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Curcumin supplementation in the treatment of patients with cancer: a systematic review
title Curcumin supplementation in the treatment of patients with cancer: a systematic review
spellingShingle Curcumin supplementation in the treatment of patients with cancer: a systematic review
Andrade da Anunciação, Taise
Curcumin. Cancer. Systematic review. Anti-inflammatory profile. Anti-oxidant profile.
title_short Curcumin supplementation in the treatment of patients with cancer: a systematic review
title_full Curcumin supplementation in the treatment of patients with cancer: a systematic review
title_fullStr Curcumin supplementation in the treatment of patients with cancer: a systematic review
title_full_unstemmed Curcumin supplementation in the treatment of patients with cancer: a systematic review
title_sort Curcumin supplementation in the treatment of patients with cancer: a systematic review
author Andrade da Anunciação, Taise
author_facet Andrade da Anunciação, Taise
Spindola Garcez, Laís
Miranda Pereira, Emile
Alves de Oliveira Queiroz, Valterlinda
Ribas de Farias Costa, Priscila
Pereira Magalhães de Oliveira, Lucivalda
author_role author
author2 Spindola Garcez, Laís
Miranda Pereira, Emile
Alves de Oliveira Queiroz, Valterlinda
Ribas de Farias Costa, Priscila
Pereira Magalhães de Oliveira, Lucivalda
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Andrade da Anunciação, Taise
Spindola Garcez, Laís
Miranda Pereira, Emile
Alves de Oliveira Queiroz, Valterlinda
Ribas de Farias Costa, Priscila
Pereira Magalhães de Oliveira, Lucivalda
dc.subject.por.fl_str_mv Curcumin. Cancer. Systematic review. Anti-inflammatory profile. Anti-oxidant profile.
topic Curcumin. Cancer. Systematic review. Anti-inflammatory profile. Anti-oxidant profile.
description Feeding with high levels of phytochemicals, including curcumin, may be a therapeutic option for diseases such as cancer which is a public health problem. The aim of this study was to systematically review the results of clinical trials investigating the effect of oral curcumin supplementation on anti-inflammatory and antioxidant profiles, reduction of PSA levels and degree of dermatitis in radiotherapy treatment in cancer patients. The review was carried out based on the items of the PRISMA Statement. A bias risk assessment was performed according to Cochrane Collaboration criteria. Six studies met the eligibility criteria and were included in the systematic review. The results of this study are based on those obtained in the literature on the effect of curcumin on the anti-inflammatory profile, on reducing dermatitis, on PSA alteration and on anti-oxidant profile for a total of 450 individuals, comprising 259 in the intervention group and 191 in the control group. Some studies have reported improvement in biochemical and clinical indicators, with limited adverse effects and good tolerance. It was not possible to determine, with the desired degree of evidence, the effect of curcumin supplementation in the treatment of cancer patients. It is important to consider the great heterogeneity and methodological weaknesses of the studies, and that it was not possible to perform a meta-analysis of the data available in the literature.
publishDate 2022
dc.date.none.fl_str_mv 2022-11-08
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/200985
url https://www.revistas.usp.br/bjps/article/view/200985
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/200985/185166
https://www.revistas.usp.br/bjps/article/view/200985/185167
dc.rights.driver.fl_str_mv Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 57 (2021)
Brazilian Journal of Pharmaceutical Sciences; v. 57 (2021)
Brazilian Journal of Pharmaceutical Sciences; Vol. 57 (2021)
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222915594027008